Answer
Gilteritinib fumarate is not recommended during pregnancy because it can cause foetal harm, human pregnancy data are absent or limited, and rat studies showed suppressed foetal growth, embryo-foetal deaths and birth defects.
Sources for this answer
- Gilteritinib Astellas 40 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked